Scott Frost shares his insights from our newsletter:
“That’s a good problem to have.”
People love that phrase.
Your garden produced so many tomatoes you’re leaving bags of them on your neighbors’ porches.
Your team keeps winning and now you have to rearrange your October plans.
Good problems.
But sometimes good news creates a problem with much higher stakes.
Researchers are making genuinely exciting progress with cancer vaccines.
Despite the name, these aren’t vaccines designed to keep you from getting cancer in the first place.
They’re designed to teach the immune system to recognize and attack cancer that’s already there.
Think about that for a second.
We may be able to teach the body to recognize cancer as the enemy and go after it.
That’s pretty incredible.
The defense system was already there. Now we’re learning how to give it better instructions.
None are approved for mesothelioma yet. The research is still in clinical trials.
But it’s moving in a promising direction.
The hope, of course, is more time.
But more time can mean more treatment.
More scans. More infusions. More trips to specialists.
More time away from work for patients and caregivers.
Living longer comes with an invoice.
It’s a strange thing to say about such good news, but it matters. Especially when a legal settlement only happens once.
You don’t get to settle a case today, find out three years from now that a new treatment is available, and reopen the file because nobody accounted for what that treatment might cost.
That’s why looking at today’s medical bills isn’t enough.
Nobody knows exactly what mesothelioma treatment will look like five years from now.
I hope today’s breakthroughs are just the beginning.
— Scott Frost
(866) FROST-WINS
P.S. If mesothelioma or an asbestos-related cancer has affected your family, feel free to reach out. We’re always happy to answer questions.
From Exposure to Closure ®
